The study by researchers from ICMR & Bharat Biotech presents interim results from phase 2 trial, along with analysis from 3-month follow-up of phase 1 trial participants.
Bharat Biotech's phase-3 trial was conducted on 25,800 participants between 18-98 years of age, including 2,433 over the age of 60 and 4,500 with comorbidities.
Over 10 crore people in two priority groups — above 60 years and those above 45 years with comorbidities — will be covered in the 2nd phase that began Monday.
Govt said Wednesday that those getting the Covid-19 vaccination at private hospitals will have to pay for it, setting the stage for their participation in immunisation drive.
Covaxin is one of two vaccines being administered as part of India’s Covid vaccination drive. It was given conditional emergency-use nod in absence of complete Phase 3 trial data.
Govt considers the 50+ category to be the 'biggest priority group' in the city, and the numbers are being included in the database on the basis of electoral roll figures.
Minutes from Jan meetings showed that India’s drug regulatory agency insisted on seeing efficacy data for Covaxin, before approving it for a restricted use in 'clinical trial mode'.
India’s hills are caught in a time warp of repeating disasters. It’s a sign for the authorities leading the lofty development plans that have become the fulcrum of the tourism economy.
A public meeting, where the women voiced their protest, took place this month in Delhi, grounded on the findings of an AIDWA survey, covering 9,000 women borrowers.
Joint submarine patrol ‘covered more than 2,000 nautical miles’ and was joined by Russian support vessels. Beijing maintains exercise ‘not directed against any third party’.
From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.
COMMENTS